The new low-dose transdermal contraceptive system (Twirla (R)): results from preclinical and Phase III trials

Nelson, AL

Nelson, AL (corresponding author), Western Univ Hlth Sci, Obstet & Gynecol, Pomona, CA 91766 USA.; Nelson, AL (corresponding author), Univ Calif Los Angeles, Obstet & Gynecol, Los Angeles, CA 90095 USA.; Nelson, AL (corresponding author), Univ Southern Calif USC, Obstet & Gynecol, Los Angeles, CA 90007 USA.; Nelson, AL (corresponding author), Essential Access Hlth, Los Angeles, CA 90010 USA.

THERAPEUTIC DELIVERY, 2021; 12 (7): 501

Abstract

A new low-dose, once-a-week contraceptive transdermal delivery system (TDS) with 2.3-mg ethinyl estradiol (EE) and 2.6-mg levonorgestrel (LNG; Twirla ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索